MHM Magazine

References: 1. AROQUET XR 50/150/200/300/400 (prolonged-release tablet) professional information, April 2021. 2. Bauer M, etal . A pooled analysis of two randomised, placebo-controlled studies of extended release quetiapine fumarate adjunctive to antidepressant therapy in patients with majordepressivedisorder. JAffectDis 2010;127:19-30.doi:10.1016/j.jad.2010.08.032. S5 AROQUETXR50 (prolonged-release tablet).Eachprolonged-release tablet containsquetiapine fumarateequivalent to50mgofquetiapine.RegNo.:48/2.6.5/0011. S5 AROQUETXR150 (prolonged-release tablet).Eachprolonged-release tablet containsquetiapine fumarateequivalent to150mg of quetiapine. Reg No.: 52/2.6.5/0998. S5 AROQUET XR 200 (prolonged-release tablet). Each prolonged-release tablet contains quetiapine fumarate equivalent to 200 mg of quetiapine. Reg No.: 48/2.6.5/0012. S5 AROQUET XR 300 (prolonged-release tablet). Each prolonged-release tablet contains quetiapine fumarateequivalent to300mgofquetiapine.RegNo.:48/2.6.5/0013.For fullprescribing information refer to theprofessional informationapprovedby theMedicinesRegulatoryAuthority (SAHPRA). Accord Healthcare (Pty) Ltd. Reg. No.: 2004/011257/07. Tel: +27 11 234 5701/2/3, Fax: +27 11 234 5700, Customer Care No.: +27 11 234 5950. Building 2, Tuscany Office Park, 6 Coombe Place, Rivonia, 2128, Gauteng, SOUTHAFRICA.PostnetSuite182,PrivateBagX51,Rivonia,2128.Email:medinfo@accordhealth.co.za.Website:www.accord-healthcare.co.za.ARO/001/SEP23/AD. MANAGE UNCONTROLLED SYMPTOMS OF MAJOR DEPRESSIVE DISORDER (MDD) 1 M A J O R D E P R E S S I V E D I S O R D E R Once daily quetiapine XR (Aroquet XR) 1 has demonstrated efficacy both as monotherapy in the short-term and long-term, and as adjunct therapy to existing antidepressants in patients with MDD 2 Help them take CONTROL with Aroquet XR 1 THE ACCORD DIFFERENCE IN MENTAL HEALTH